Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Nova
NVMI
$8.7B
| $7.07M | ﹤0.01% |
62,593
| – | – |
|
1102
Ultragenyx Pharmaceutical
RARE
$2.96B
| $7.05M | ﹤0.01% |
152,852
+9,100
| +6% | +$420K |
|
1103
Glaukos
GKOS
$4.78B
| $7.05M | ﹤0.01% |
99,000
-4,000
| -4% | -$285K |
|
1104
Intellia Therapeutics
NTLA
$1.24B
| $7.03M | ﹤0.01% |
172,500
+19,700
| +13% | +$803K |
|
1105
Denali Therapeutics
DNLI
$2.13B
| $7.03M | ﹤0.01% |
238,100
+32,900
| +16% | +$971K |
|
1106
Azenta
AZTA
$1.38B
| $7.02M | ﹤0.01% |
150,400
-11,500
| -7% | -$537K |
|
1107
American States Water
AWR
$2.82B
| $7M | ﹤0.01% |
80,500
+700
| +0.9% | +$60.9K |
|
1108
Brighthouse Financial
BHF
$2.83B
| $6.98M | ﹤0.01% |
147,400
-1,800
| -1% | -$85.2K |
|
1109
Grand Canyon Education
LOPE
$5.89B
| $6.98M | ﹤0.01% |
67,600
+400
| +0.6% | +$41.3K |
|
1110
Coca-Cola Consolidated
COKE
$10.6B
| $6.97M | ﹤0.01% |
109,650
+1,000
| +0.9% | +$63.6K |
|
1111
AppFolio
APPF
$10B
| $6.97M | ﹤0.01% |
40,500
-1,300
| -3% | -$224K |
|
1112
Spectrum Brands
SPB
$1.3B
| $6.97M | ﹤0.01% |
89,299
+1,300
| +1% | +$101K |
|
1113
TAL Education Group
TAL
$6.61B
| $6.97M | ﹤0.01% |
1,169,165
-8,600
| -0.7% | -$51.3K |
|
1114
LCI Industries
LCII
$2.45B
| $6.96M | ﹤0.01% |
55,100
+200
| +0.4% | +$25.3K |
|
|
NVEI
1115
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $6.96M | ﹤0.01% |
235,400
-26,600
| -10% | -$786K |
|
1116
Lyft
LYFT
$7.7B
| $6.94M | ﹤0.01% |
724,000
+39,600
| +6% | +$380K |
|
1117
iRhythm Technologies
IRTC
$5.71B
| $6.93M | ﹤0.01% |
66,400
+1,400
| +2% | +$146K |
|
|
ERF
1118
DELISTED
Enerplus Corporation
ERF
| $6.92M | ﹤0.01% |
476,855
-12,200
| -2% | -$177K |
|
1119
Freshpet
FRPT
$2.66B
| $6.88M | ﹤0.01% |
104,550
+900
| +0.9% | +$59.2K |
|
1120
FTAI Aviation
FTAI
$17.5B
| $6.88M | ﹤0.01% |
217,192
+2,100
| +1% | +$66.5K |
|
1121
Pacific Biosciences
PACB
$357M
| $6.87M | ﹤0.01% |
516,646
+53,000
| +11% | +$705K |
|
1122
Brink's
BCO
$4.88B
| $6.87M | ﹤0.01% |
101,300
+1,000
| +1% | +$67.8K |
|
1123
Progyny
PGNY
$1.94B
| $6.86M | ﹤0.01% |
174,500
+14,200
| +9% | +$559K |
|
1124
Assured Guaranty
AGO
$3.94B
| $6.86M | ﹤0.01% |
123,000
| – | – |
|
1125
Ambarella
AMBA
$3.44B
| $6.86M | ﹤0.01% |
81,933
+3,100
| +4% | +$259K |
|